These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17949962)

  • 1. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
    Yamauchi J; Takai S; Matsushima-Nishiwaki R; Hanai Y; Doi T; Kato H; Ogura S; Kato K; Tokuda H; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):173-9. PubMed ID: 17949962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
    Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
    Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
    J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
    Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
    FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of p42/p44 mitogen-activated protein kinase in prostaglandin f(2alpha)-stimulated induction of heat shock protein 27 in osteoblasts.
    Kozawa O; Tokuda H; Miwa M; Ito H; Matsuno H; Niwa M; Kato K; Uematsu T
    J Cell Biochem; 1999 Dec; 75(4):610-9. PubMed ID: 10572244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts.
    Kuroyanagi G; Mizutani J; Kondo A; Yamamoto N; Matsushima-Nishiwaki R; Otsuka T; Kozawa O; Tokuda H
    Prostaglandins Leukot Essent Fatty Acids; 2014 Sep; 91(3):73-80. PubMed ID: 24813642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin gallate attenuates the induction of HSP27 stimulated by sphingosine 1-phosphate via suppression of phosphatidylinositol 3-kinase/Akt pathway in osteoblasts.
    Natsume H; Adachi S; Takai S; Tokuda H; Matsushima-Nishiwaki R; Minamitani C; Yamauchi J; Kato K; Mizutani J; Kozawa O; Otsuka T
    Int J Mol Med; 2009 Aug; 24(2):197-203. PubMed ID: 19578793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement by HSP90 inhibitor of PGD2-stimulated HSP27 induction in osteoblasts: Suppression of SAPK/JNK and p38 MAP kinase.
    Kim W; Tokuda H; Kawabata T; Fujita K; Sakai G; Nakashima D; Tachi J; Kuroyanagi G; Matsushima-Nishiwaki R; Tanabe K; Otsuka T; Iida H; Kozawa O
    Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106327. PubMed ID: 30946899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
    Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
    Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of p44/p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells.
    Hanai Y; Tokuda H; Ishisaki A; Matsushima-Nishiwaki R; Nakamura N; Yoshida M; Takai S; Ohta T; Kozawa O
    Mol Cell Endocrinol; 2006 Jun; 251(1-2):42-8. PubMed ID: 16616413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Epigallocatechin gallate inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
    Kato K; Otsuka T; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
    Mol Med Rep; 2011; 4(2):297-300. PubMed ID: 21468567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
    Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
    J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) in prostaglandin F2alpha-induced heat shock protein 27 in osteoblasts.
    Tokuda H; Niwa M; Ishisaki A; Nakajima K; Ito H; Kato K; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):441-7. PubMed ID: 15062846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of prostaglandin D(2)-stimulated heat shock protein 27 induction in osteoblasts.
    Kozawa O; Otsuka T; Hatakeyama D; Niwa M; Matsuno H; Ito H; Kato K; Matsui N; Uematsu T
    Cell Signal; 2001 Aug; 13(8):535-41. PubMed ID: 11483406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate enhances prostaglandin D2-stimulated heat shock protein 27 induction in osteoblasts.
    Yoshida M; Niwa M; Ishisaki A; Hirade K; Ito H; Shimizu K; Kato K; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2004 Dec; 71(6):351-62. PubMed ID: 15519494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
    Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
    Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation by retinoic acid of transforming growth factor-beta-stimulated heat shock protein 27 induction in osteoblasts: involvement of mitogen-activated protein kinases.
    Hatakeyama D; Kozawa O; Niwa M; Matsuno H; Ito H; Kato K; Tatematsu N; Shibata T; Uematsu T
    Biochim Biophys Acta; 2002 Feb; 1589(1):15-30. PubMed ID: 11909638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minodronate suppresses prostaglandin F2alpha-induced vascular endothelial growth factor synthesis in osteoblasts.
    Hanai Y; Tokuda H; Takai S; Harada A; Ohta T; Kozawa O
    Horm Metab Res; 2006 Mar; 38(3):152-8. PubMed ID: 16673205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of heat shock protein 27 in transforming growth factor-β-stimulated vascular endothelial growth factor release in osteoblasts.
    Kato K; Tokuda H; Adachi S; Matsushima-Nishiwaki R; Yamauchi J; Natsume H; Minamitani C; Mizutani J; Otsuka T; Kozawa O
    Int J Mol Med; 2011 Mar; 27(3):423-8. PubMed ID: 21225223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiludronate inhibits prostaglandin F2alpha-induced vascular endothelial growth factor synthesis in osteoblasts.
    Yoshida M; Tokuda H; Ishisaki A; Kanno Y; Harada A; Shimuzu K; Kozawa O
    Mol Cell Endocrinol; 2005 May; 236(1-2):59-66. PubMed ID: 15922088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.